{"created":"2024-02-09T01:58:42.337990+00:00","id":2000177,"links":{},"metadata":{"_buckets":{"deposit":"084d7876-aaab-47b9-a150-3807de04e944"},"_deposit":{"created_by":14,"id":"2000177","owner":"14","owners":[14],"pid":{"revision_id":0,"type":"depid","value":"2000177"},"status":"published"},"_oai":{"id":"oai:dmu.repo.nii.ac.jp:02000177","sets":["223:1706758590590"]},"author_link":[],"control_number":"2000177","item_10001_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2023-12-25","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"4","bibliographicPageEnd":"288","bibliographicPageStart":"281","bibliographicVolumeNumber":"2","bibliographic_titles":[{"bibliographic_title":"Dokkyo Medical Journal","bibliographic_titleLang":"en"}]}]},"item_10001_description_6":{"attribute_name":"内容記述","attribute_value_mlt":[{"subitem_description":"ANCA-associated rapidly progressive glomerulonephritis has been treated with steroid pulse therapy (mPSL pulse), cyclophosphamide pulse therapy (IVCY), rituximab (RTX), and plasma exchange (PE), but the differences in renal and life outcomes are not fully understood. To determine the long-term prognostic impact of plasma exchange in ANCA-associated rapidly progressive glomerulonephritis, we conducted a retrospective observational study with stratification by treatment modality to determine the prognostic impact of plasma exchange in ANCA-associated rapidly progressive glomerulonephritis. Eighty patients with ANCA-associated glomerulonephritis who underwent renal biopsy at our hospital were divided into 5 groups, and the renal and life prognosis were evaluated. IVCY and RTX significantly improved renal survival compared with steroid therapy and PE. PE and PSL oral groups did not improve renal prognosis, but survived without death during the observation period. PE is introduced in patients requiring hemodialysis at biopsy to rapidly reduce ANCA levels with favorable life prognosis.","subitem_description_language":"en","subitem_description_type":"Abstract"}]},"item_10001_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"Dokkyo Medical Society"}]},"item_10001_relation_14":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_type":"isIdenticalTo","subitem_relation_type_id":{"subitem_relation_type_id_text":"https://doi.org/10.51040/dkmj.2023-006","subitem_relation_type_select":"DOI"}}]},"item_10001_source_id_11":{"attribute_name":"書誌レコードID","attribute_value_mlt":[{"subitem_source_identifier":"AA12941861","subitem_source_identifier_type":"NCID"}]},"item_10001_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"2436-522X","subitem_source_identifier_type":"EISSN"}]},"item_10001_text_33":{"attribute_name":"記事種別","attribute_value_mlt":[{"subitem_text_value":"Original"}]},"item_10001_version_type_20":{"attribute_name":"出版タイプ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"open access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_abf2"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Yokoyama, Shohei","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Tojo, Akihiro","creatorNameLang":"en"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2024-02-09"}],"filename":"DKMJ-2-4-4.pdf","filesize":[{"value":"645 KB"}],"format":"application/pdf","licensetype":"license_5","mimetype":"application/pdf","url":{"objectType":"fulltext","url":"https://dmu.repo.nii.ac.jp/record/2000177/files/DKMJ-2-4-4.pdf"},"version_id":"fad59958-e18d-468a-96a0-2a6913192867"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"ANCA","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"plasma exchange","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"steroid","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"cyclophosphamide","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"rituximab","subitem_subject_language":"en","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Comparison of the Therapeutic Effects on the Renal and Life Prognosis in ANCA-associated Nephritis","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Comparison of the Therapeutic Effects on the Renal and Life Prognosis in ANCA-associated Nephritis","subitem_title_language":"en"}]},"item_type_id":"10001","owner":"14","path":["1706758590590"],"publish_date":"2024-02-09","publish_status":"0","recid":"2000177","relation_version_is_last":true,"title":["Comparison of the Therapeutic Effects on the Renal and Life Prognosis in ANCA-associated Nephritis"],"weko_creator_id":"14","weko_shared_id":-1},"updated":"2024-04-03T04:27:35.879334+00:00"}